The total return over the past 12 months is -36.84% vs. +16.94% for the S&P 500. So far it's up -13.72% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (36.84%) | (21.16%) | (20.85%) | (3.96%) | N/A | N/A |
| Total Return CAGR | (36.84%) | (21.16%) | (20.85%) | (3.96%) | N/A | N/A |
| Revenue CAGR | +3.99% | +8.14% | +9.90% | +12.25% | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | +7.02% | +36.71% | (0.84%) | +8.20% | N/A | N/A |
| Operating Cash Flow CAGR | (2.24%) | +16.42% | +23.92% | +7.30% | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Surgery Partners, Inc. (SGRY)
| Year | Start price | End price | SGRY Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $15.45 | $13.33 | (13.72%) | +14.51% | (28.23%) |
| 2025 | $21.17 | $15.45 | (27.02%) | +17.72% | (44.74%) |
| 2024 | $31.99 | $21.17 | (33.82%) | +24.89% | (58.71%) |
| 2023 | $27.86 | $31.99 | +14.82% | +26.19% | (11.37%) |
| 2022 | $53.41 | $27.86 | (47.84%) | (18.17%) | (29.67%) |
| 2021 | $29.01 | $53.41 | +84.11% | +28.74% | +55.37% |
| 2020 | $15.66 | $29.01 | +85.31% | +18.37% | +66.94% |
| 2019 | $9.79 | $15.66 | +59.91% | +31.22% | +28.69% |
| 2018 | $12.10 | $9.79 | (19.09%) | (4.56%) | (14.53%) |
| 2017 | $15.85 | $12.10 | (23.66%) | +21.70% | (45.36%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
